Andrae B, Andersson TML, Lambert PC, Kemetli L, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg S, Sparén P. Screening and cervical cancer cure: a population-based cohort study. BMJ, 2012 Mar 1;344:e900.

Arnheim-Dahlström L och Madrid Scheller N: HPV-vaccination inte associerad med multipel skleros eller andra myelinförstörande sjukdomar, Läkartidningen. 2015;112:DAY7.

Arnheim-Dahlstrom L, Pasternak B, Svanstrom H, Sparen P, Hviid A. Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study. BMJ. 2013;347:f5906. Epub 2013/10/11.

Baussano, I., Dillner, J., Lazzarato, F., Ronco, G., Franceschi, S. Upscaling human papillomavirus vaccination in high-income countries: impact assessment based on transmission model. Infectious Agents of Cancer. 2014 Jan 20;9(1):4. [Epub ahead of print]

Baussano, I., Elfström, K. M., Lazzarato, F., Gillio-Tos, A., De Marco, L., Carozzi, F., Del Mistro, A., Dillner, J., Franceschi, S., Ronco, G. Type-specific HPV biological features: validated model-based estimates. PLoS One. 2013 Nov 29;8(11):e81171.

Baussano I., Lazzarato F., Ronco G., Dillner J., Franceschi S. Benefits of catch-up in vaccination against human papillomavirus in medium- and low-income countries. International Journal of Cancer. 133. 1876-1881. 2013.

Darlin, L., Borgfeldt, C., Forslund, O., Hénic, E., Hortlund, M., Dillner, J., Kanisto, P. Comparison of use of vaginal HPV self-sampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical screening. Journal of Clinical Virology. 58. 155-160. 2013.

Darlin, L., Borgfeldt, C., Forslund, O., Hénic, E., Dillner, J., Kannistö, P. Vaginal self- sampling without preservative for human papillomavirus testing shows good sensitivity. Journal of Clinical Virology. 56. 52-56. 2013.

Eklund, C., Forslund, O., Wallin, K.L., Dillner, J. Global improvement in genotyping of Human Papillomavirus DNA: The 2011 HPV LabNet International Proficiency Study. Journal of Clinical Microbiology. 52. 449-459. 2014.

Elfström KM, Dillner J, Arnheim-Dahlström L. Organization and quality of HPV vaccination programs in Europe,  Vaccine, 2015 Mar 30;33(14):1673-81. doi: 10.1016/j.vaccine.2015.02.028. Epub 2015 Feb 23.PMID: 25720792

Elfström KM, Lazzarato F, Franceschi S, Dillner J, Baussano I. Human Papillomavirus Vaccination of Boys and Extended Catch-up Vaccination: Effects on the Resilience of Programs. J Infect Dis. 2016 Jan 15;213(2):199-205. doi: 10.1093/infdis/jiv368. Epub 2015 Jul 3.

Elfstrom KM, Smelov V, Johansson AL, Eklund C, Naucler P, Arnheim-Dahlstrom L, et al. Long-term HPV type-specific risks for ASCUS and LSIL: a 14-year follow-up of a randomized primary HPV screening trial. Int J Cancer. 2015;136(2):350-9.

Elfström KM, Smelov V, Johansson AL, Eklund C, Nauclér P, Arnheim-Dahlström L, Dillner J. Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial. BMJ. 2014 Jan 16;348:g130.

Herweijer E, Feldman AL, Ploner A, Arnheim-Dahlström L, Uhnoo I, Netterlid E, Dillner J, Sparén P, Sundström K, The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study. PLoS One. 2015 Jul 28;10(7):e0134185. doi: 10.1371/journal.pone. 0134185. eCollection 2015. PMID: 26218492

Herweijer E, Leval A, Ploner A, Eloranta S, Simard JF, Dillner J , Netterlid E, Sparén P, Arnheim-Dahlström L. Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma Jama. 2014;311(6):597-603. Epub 2014/02/13.

Herweijer E, Sundström K, Ploner A, Uhnoo I, Sparén P, Arnheim-Dahlström L. Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study. Int J Cancer. 2016 Feb 9. doi: 10.1002/ijc.30035. [Epub ahead of print]

Johansson, H., Bzhalava, D., Ekström, J., Hultin, E., Dillner, J., Forslund, O. Metagenomic sequencing of “HPV-negative” condylomas detects novel putative HPV types. Virology. 440. 1-7. 2013.

Hortlund M, Sundström K, Lamin H2, Hjerpe A, Dillner J. Laboratory audit as part of the quality assessment of a primary HPV-screening program. J Clin Virol. 2015 Dec 24;75:33-36. doi: 10.1016/j.jcv.2015.12.007.

Lagheden C1, Eklund C1, Kleppe SN1, Unger ER2, Dillner J3, Sundström K1. Validation of a standardized extraction method for formalin-fixed paraffin-embedded tissue samples. J Clin Virol. 2016 Apr 27;80:36-39. doi: 10.1016/j.jcv.2016.04.016. [Epub ahead of print

Leval A, Herweijer E, Arnheim-Dahlstrom L, Walum H, Frans E, Sparen P , Simard JF. Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability. J Infect Dis. 2012;206(6):860-6. Epub 2012/07/21.

Leval, A., Herweijer, E., Ploner, A., Eloranta, S., Fridman Simard, J., Dillner, J., Young, C., Netterlid, E., Sparén, P., Arnheim-Dahlström, L. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study. Journal of the National Cancer Institute. 105. 469-474. 2013.

Nygård, M., Røysland, K., Campbell, S., Dillner, J. Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme.BMJ Open 2013;4:e003460.doi:10.1136/bmjopen-2013-003460.

Ploner A, Herweijer E, Arnheim-Dahlström L, Number of human papillomavirus vaccine doses and condyloma–reply.,JAMA. 2014 Jun 18;311(23):2439-40. doi: 10.1001/jama.2014.5012. No abstract available.PMID: 24938570

Ronco G, Dillner J, Elfström KM, Tunesi S, Snijders PJ, Arbyn M, Kitchener H, Segnan N, Gilham C, Giorgi-Rossi P, Berkhof J, Peto J, Meijer CJ; International HPV screening working group. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014 Feb 8;383(9916):524-32. doi: 10.1016/S0140-6736(13)62218-7. Epub 2013 Nov 3.

Scheller NM1, Svanström H1, Pasternak B1, Arnheim-Dahlström L2, Sundström K3, Fink K4, Hviid A1; Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system. JAMA. 2015 Jan 6;313(1):54-61. doi: 10.1001/jama.2014.16946.

Smelov V, Elfstrom KM, Johansson AL, Eklund C, Naucler P, Arnheim-Dahlstrom L, et al. Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial. Int J Cancer. 2015;136(5):1171-80.

Strander B, Hällgren J, Sparén P. Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality.BMJ. 2014 Jan 14;348:f7361

Sturegård, E., Johansson, H., Ekström, J., Hansson, B.G., Johnsson, A., Gustafsson, E., Dillner, J., Forslund, O. Human papillomavirus typing in reporting of condyloma. Sexually Transmitted Diseases. 40. 123-129. 2013.

Sundström K, Ploner A, Arnheim-Dahlström L, Eloranta S, Palmgren J, Adami HO, Ylitalo Helm N, Sparén P, Dillner J. Interactions Between High- and Low-Risk HPV Types Reduce the Risk of Squamous Cervical Cancer. J Natl Cancer Inst. 2015 Jul 9;107(10). pii: djv185. Print 2015 Oct. PMID: 26160881

Sundström, K., Ploner, A., Dahlström, L.A., Palmgren, J., Dillner, J., Adami, H.O., Ylitalo, N., Sparén, P. Prospective study of HPV16 viral load and risk of in situ and invasive squamous cervical cancer. Cancer Epidemiology, Biomarkers and Prevention. 22. 150-158. 2013.

Söderlund-Strand, A., Kjellberg, L., Dillner, J. Human Papilloma type-specific persistence and recurrence after treatment for cervical dysplasia.Journal of Medical Virology.2013 Oct 12.doi: 10.1002/jmv.23806. [Epub ahead of print].

Söderlund-Strand, A., Dillner, J. High throughput monitoring of Human Papillomavirus type distribution.Cancer Epidemiology, Biomarkers and Prevention. 22. 242-250. 2013.

Tota, J.E., Ramanakumar, A.V., Jiang, M., Dillner, J., Walter, S.D., Kaufman, J.S., Coutlée, F., Villa, L.L., Franco, E.L. Epidemiologic approaches to evaluating the potential for Human Papillomavirus type replacement postvaccination. American Journal of Epidemiology. 178. 625-634. 2013.

Vaccarella, S., Söderlund-Strand, A., Franceschi, S., Plummer, M., Dillner, J. Patterns of human papillomavirus types in multiple infections: an analysis in women and men of the High Throughput Human Papilloma Monitoring Study. PLoS One. 8. e71617. 2013.

Wang J, Andrae B, Sundström K, Ström P, Ploner A, Elfström KM, Arnheim-Dahlström L, Dillner J, Sparén P. Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study.BMJ. 2016 Feb 11;352:i276. doi: 10.1136/bmj.i276.